With more than 12 years of clinical operations experience, Silvio joined the Anaveon team in April 2021 as Clinical Trial Leader. Previously, he had the opportunity to work for large pharmaceutical companies but also as consultant acting as project manager supporting mainly small and mid-sized biotechnology companies across Europe. Through his involvement in several early immunology and cell therapy drugs development clinical studies, Silvio has decided to continue learning and boosting his clinical research knowledge through post-graduate education programmes.
- Anaveon presents clinical trial OMNIA-2 at the American Society of Clinical Oncology 2023 Annual MeetingJune 5, 2023
- Anaveon Presents Trial in Progress Data for OMNIA-1 at the American Society of Clinical Oncology 2023 Annual MeetingJune 3, 2023
- Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual MeetingApril 18, 2023